Dr. Michiel Strijbos is a Consultant Medical Oncologist at the Sint-Augustinus Hospital in Wilrijk, Belgium. He trained at Leuven University in Belgium and the Erasmus University in Rotterdam, Netherlands, where he graduated in 2004.
In his daily practice, Dr. Strijbos focuses on the research and treatment of genitourinary malignancies. He is currently active in several task forces and committees with regards to GU malignancies and is a principal investigator in several clinical trials in this field. He is also a member of the European Organisation for Research and Treatment of Cancer (EORTC) GU group.
Since early on in his carrier, Dr. Strijbos has played an active role within ESMO. He participated in the Young Oncologist Committee and the first Leaders Generation Programme. Currently, he is chair of the Practicing Oncologists Working Group and serves as member of the Publishing Group and Educational Committee.
Last update: June 2021